Takuya Koie

A novel strategy for evasion of NK cell immunity by tumours expressing core2 O‐glycans

Shigeru Tsuboi, Mihoko Sutoh, Shingo Hatakeyama et al. · The EMBO Journal · 2011 · 159 citations · Full text

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka et al. · European Urology Focus · 2017 · 95 citations · Full text

Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer

Tohru Yoneyama, Chikara Οhyama, Shingo Hatakeyama et al. · Biochemical and Biophysical Research Communications · 2014 · 81 citations

Glycoproteomics, Urology, Genitourinary Cancer +11

Uterus-, Fallopian Tube-, Ovary-, and Vagina-sparing Cystectomy Followed by U-shaped Ileal Neobladder Construction for Female Bladder Cancer Patients: Oncological and Functional Outcomes

Takuya Koie, Shingo Hatakeyama, Takahiro Yoneyama et al. · Urology · 2009 · 73 citations

Gynecologic Surgery, Urology, Surgical Oncology +14

Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity

Teppei Okamoto, Mihoko Sutoh Yoneyama, Shingo Hatakeyama et al. · Molecular Medicine Reports · 2012 · 60 citations · Full text

Glycoproteomics, Cancer Immunosurveillance, Glycosylation +14